Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Organigram Global Inc.NASDAQ: OGI

Net Margin · Q2 FY2026 · quarter ended Mar 2026

Net margin narrows to -1.5%

Net margin was -1.5% in Q2 FY2026, down 66.3 pp from a year earlier. On a trailing-twelve-month basis it was -9.2%, down 17.9 pp year over year.

Context

  • Net margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether net margin reaches the consensus estimate from 3 analysts of 20.2% for the fiscal year ending Sep 2026, up from -9.6% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-1.5%-33.0 pp QoQ
Last fiscal yearSep 2025
-9.6%+18.9 pp YoY
LTMMar 2026
-9.2%-17.9 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-66.3 pp+7.9 pp+74.2 pp
1 year+18.9 pp+29.7 pp+10.8 pp
3 years—+12.4 pp—
5 years+13.7 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2025
-9.6%
Year-over-year change
+18.9pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How OGI compares with its peers on the latest reported figures

  • OGI's LTM Mar 2026 net margin of -9.2% is the 3rd highest of the 10 companies compared; the peer median is -25.2%.
  • Its year-over-year change of -17.9 pp is the 6th highest of 9, against a peer median of +1.2 pp.
OGI Competitors Peer median
Net Margin for OGI and competitors
Company Period LTM level YoY 3-year change
ELMDElectromed, Inc.LTM Mar 202614.1% +2.4 pp+6.2 pp
INFUInfuSystem Holdings, Inc.LTM Mar 20265.6% +3.2 pp+4.6 pp
OGIOrganigram Global Inc.LTM Mar 2026-9.2% -17.9 pp—
DERMJourney Medical CorporationLTM Mar 2026-14.8% -0.1 pp+21.7 pp
ACBAurora Cannabis Inc.LTM Mar 2026-24.1% -24.6 pp+326.9 pp
LFCRLifecore Biomedical, Inc.LTM Mar 2026-25.2% —+74.8 pp
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026-167.0% +2130.9 pp+793.9 pp
HSDTSolana CompanyLTM Mar 2026-1427.1% +1583.0 pp+1108.5 pp
IVAInventiva S.A.FY2025-7587.8% -5585.1 pp-7142.2 pp
RNACCartesian Therapeutics, Inc.LTM Mar 2026-8550.6% -8438.5 pp-4690.6 pp
Peer median (excluding OGI) -25.2%+1.2 pp+21.7 pp

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M186.09M
Cost of Revenue107.56M114.24M114.13M112.32M179.26M
Gross Profit(28.4M)31.57M35.07M47.52M6.83M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.47M59.21M71.68M68.14M86.88M
Operating Expenses63.42M74.72M271.48M83.2M70.24M
Depreciation & Amortization31.03M24.91M23.43M12.08M12.91M
EBITDA(96.71M)10.97M(25.37M)(23.59M)(14.76M)
EBITDA Margin-122.2%7.5%-17.0%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(63.41M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M0825.7K
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M(184.21M)(9.77M)35.74M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(27.66M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)0(9.89M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(17.78M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.14)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.14)
Weighted Avg Shares64.03M80.01M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M85.3M81.29M95.29M127.67M

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.